Health Care/Hospital

Robotware.ai Advances AI Poultry Disease Detection PoC in Malaysia with SDEC

KUALA LUMPUR, Malaysia, Dec. 17, 2025 /PRNewswire/ -- Robotware.ai , a Korea-based artificial intelligence company specializing in livestock intelligence solutions, is advancing itsproof-of-concept (PoC) deployment in Malaysia in collaboration with Sarawak Digital Economy Corporation (SDEC) , ...

2025-12-17 09:00 2663

Aussie medtech Ferronova raises another $6 million to advance image-guided cancer surgery

ADELAIDE, Australia, Dec. 17, 2025 /PRNewswire/ -- Australian company Ferronova has raised a further$6 million to progress the commercialisation of a novel nanoparticle image-guided surgery solution seeking to improve identification of cancer cells and reduce the risk of undetected recurrence fol...

2025-12-17 08:30 2522

Jiaying Pharmaceutical: A New Pathway for the Industrialization of Century-Old Hakka Medicine

HONG KONG, Dec. 17, 2025 /PRNewswire/ -- Recently, Meizhou in Guangdong, known as the "World Capital of the Hakka", welcomed a globally watched event, the Seventh World Hakka Entrepreneurs Convention. At this gathering that drew the attention of Hakka entrepreneurs worldwide, Guangdong Jiaying Ph...

2025-12-17 08:00 1702

Leaders Dental Unveils Vision to Become "The Central Hub of the Digital Dentistry Ecosystem," Accelerates AI and IoT-Driven Production Automation

SEOUL, South Korea, Dec. 17, 2025 /PRNewswire/ -- Leaders Dental Laboratory, a leading force in Korea's digital dental technology sector, has announced a new vision to position itself as "the central hub of the digital dentistry ecosystem." To realize this vision, the company is making significan...

2025-12-17 06:00 1168

All CONEC Signs MOU with MINIMAX, Taking First Step in Standardizing Digital Implant Production

SEOUL, South Korea, Dec. 17, 2025 /PRNewswire/ -- All CONEC has signed a memorandum of understanding (MOU) with Australian digital dental company MINIMAX to establish a collaborative framework for digital implant production and lay the groundwork for overseas market entry. Digital implant produc...

2025-12-17 06:00 1445

KPM Analytics Unveils the SmartChem® 800 Series, a Next-Generation Platform for High-Throughput Wet Chemistry

Industry's highest-capacity discrete analyzer delivers true walk-away automation for commercial laboratories WESTBOROUGH, Mass., Dec. 16, 2025 /PRNewswire/ -- Commercial laboratories face mounting pressure to process more samples with fewer staff while maintaining fast turnaround times. When urg...

2025-12-16 22:00 2103

Allink Biotherapeutics Completes $47M Extension Rounds of Series A to Accelerate Clinical Programs and Novel Platforms Development

* The company secured $47 million through extension rounds of Series A led by Legend Capital and Meituan Long-Z Investment with strong backing from both new investors and existing supporters * Proceeds to advance two differentiated and highly competitive ADC programs in global Phase I trials ...

2025-12-16 08:30 2454

Perennial Healthcare City Launched Adjacent to Chongqing East HSR Station, Western China's Largest HSR Hub

* Establishment of new healthcare gateway in Chongqing amid the 10th anniversary of the Chongqing Connectivity Initiative and as part of the 35th anniversary celebration ofSingapore-China diplomatic relations; * Maiden investment in Chongqing marks Perennial Holdings' sixth healthcare-centric...

2025-12-16 07:05 4467

Miroma Project Factory: Powers Clinical-Grade App for One of Australia's Largest Smoking Cessation Trials

SYDNEY, Dec. 16, 2025 /PRNewswire/ -- Miroma Project Factory (MPF) has delivered a bespoke mobile solution for Screen2Quit, part of the International Lung Study trial and one of Australia's most ambitious research studies targeting smoking cessation in people ...

2025-12-16 05:07 3818

PM-International expands child sponsorships to 8,000 with €2.88 million donation

SCHENGEN, Luxembourg, Dec. 15, 2025 /PRNewswire/ -- Global support for children in need is declining rapidly. According to World Vision, governments and institutions worldwide have cut funding for children's aid by$16.3 billion, limiting access to food, healthcare and education for millions of vu...

2025-12-15 22:13 2662

NYSE Content Advisory: Pre-Market Update + Seven of the Top 10 IPOs in 2025 List on NYSE

NEW YORK, Dec. 15, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.  Kristen Scholer delivers the pre-market update on December 15th ...

2025-12-15 22:10 3533

Rona Therapeutics Advances INHBE siRNA Into Phase 1 Clinical Development

SHANGHAI and SANTA BARBARA, Calif., Dec. 15, 2025 /PRNewswire/ -- Rona Therapeutics, a clinical-stage RNAi company, today announced the recent completion of Cohort 1 dosing in its Phase 1 first-in-human clinical study of RN3161, an investigational GalNAc-conjugated siRNA targeting INHBE for obesit...

2025-12-15 21:00 3151

Curie Oncology and Oncoshot Deploy AI to Improve Patient Outcomes in Asia

SINGAPORE, Dec. 15, 2025 /PRNewswire/ -- Curie Oncology, one of Southeast Asia's fastest-growing private oncology networks, has partnered withSingapore-based health-tech company Oncoshot to deploy AI-powered clinical research tools that help patients gain faster access to clinical trials.

2025-12-15 19:26 3249

Ascletis Announces Positive Topline Results from U.S. Phase I Study of ASC50, a Potential Best-in-Class Oral Small Molecule IL-17 Inhibitor

-  The elimination half-life of ASC50 after a single oral dose was 43, 89, 91, 87, 104, and 85 hours for 10 mg, 30 mg, 100 mg, 200 mg, 400 mg, and 600 mg, respectively, supporting once-daily or potentially once-weekly oral dosing. -  ASC50 had strong target engagement after a single oral dose, in...

2025-12-15 17:00 9143

MEDEZE Receives Frost & Sullivan's 2025 Southeast Asia Company of the Year Recognition for Leadership in Stem Cell Banking and Regenerative Medicine

The company is revolutionizing regenerative healthcare through innovation, clinical alignment, and GMP-grade excellence acrossSoutheast Asia SAN ANTONIO, Dec. 15, 2025 /PRNewswire/ -- Frost & Sullivan

2025-12-15 17:00 2355

Global Spotlight|POGMENT Biomimetic Collagen "Stable Triple Helix" Breakthrough Stuns the World--Extraordinary and Breathtaking

CHENGDU, China, Dec. 15, 2025 /PRNewswire/ -- Recently, LivingPhoenix Regenerative Technologies has captured widespread attention with its world-first "Stable Triple-Helix Biomimetic Collagen" technology, making consecutive appearances at 12 high-level academic conferences in November. These eve...

2025-12-15 16:32 2294

Medit Announces 2025 Year-End Promotion

SEOUL, South Korea, Dec. 15, 2025 /PRNewswire/ -- Medit, a global leader in 3D dental scanning solutions, announced the launch of "Medit's 2025 End of Year Promotion," a limited-time campaign delivering significant benefits to dental professionals worldwide. Dental professionals can learn more ab...

2025-12-15 16:00 3550

DMX-200 ACTION3 PHASE 3 TRIAL COMPLETES RECRUITMENT

* Recruitment successfully completed in Dimerix' ACTION3 Phase 3 clinical trial[1], which has recruited and dosed its target 286th adult patient * The ACTION3 Phase 3 trial explores the efficacy and safety of DMX-200 in FSGS patients when dosed in combination with standard-of-care blood pressu...

2025-12-15 15:02 2939

Manulife and Bupa Sign MoU for Strategic Collaboration in Hong Kong to Create a More Robust, Integrated Healthcare Network Offering Customers Greater Access and Choice

HONG KONG, Dec. 15, 2025 /PRNewswire/ -- Manulife (International) Limited ("Manulife") and Bupa International Limited ("Bupa") are pleased to announce today the signing of a Memorandum of Understanding ("MoU"), intended to establish a strategic collaboration inHong Kong that will provide customer...

2025-12-15 13:45 3286

Everest Medicines Announces 2030 Strategy and Increase in Shareholdings by Directors and Substantial Shareholder

SHANGHAI, Dec. 15, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced the launch of its 2030 Strategy, out...

2025-12-15 12:40 3996
1 ... 43444546474849 ... 541